Angiogenesis inhibitors in the treatment of prostate cancer

Angiogenesis inhibitors in the treatment of prostate cancer

Item
http://www.wikidata.org/entity/Q57139434
Progress of molecular targeted therapies for prostate cancersEndothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors.Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.Targeted therapy in prostate cancer.Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy.Antiangiogenic therapy for cancer: an updateVasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K.A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer.Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells.Severity of hematuria effects resolution in patients treated with hyperbaric oxygen therapy for radiation-induced hematuria.Aberrant BAF57 signaling facilitates prometastatic phenotypes.Nanoparticles as new tools for inhibition of cancer angiogenesis.Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours.Emerging treatments for castrate-resistant prostate cancer.Anti-angiogenic therapies in prostate cancer
P2860

Angiogenesis inhibitors in the treatment of prostate cancer

Item
http://www.wikidata.org/entity/Q57139434
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2010
@uk
name
Angiogenesis inhibitors in the treatment of prostate cancer
@en
Angiogenesis inhibitors in the treatment of prostate cancer
@nl
type
label
Angiogenesis inhibitors in the treatment of prostate cancer
@en
Angiogenesis inhibitors in the treatment of prostate cancer
@nl
prefLabel
Angiogenesis inhibitors in the treatment of prostate cancer
@en
Angiogenesis inhibitors in the treatment of prostate cancer
@nl
P1433
P1476
P2093
P275
P2860
P2888
P304
P31
P356
P407
P433
P478
P5008
P577
P6179
P698
P921
P932
P356
P1433
P1476
Angiogenesis inhibitors in the treatment of prostate cancer
@en
P2093
P275
P2860
P2888
P304
P31
P356
P407
P433
P478
P5008
P577
P6179
P698
P921
P932